您好,欢迎来到试剂仪器网! [登录] [免费注册]
试剂仪器网
位置:首页 > 产品库 > Osimertinib dimesylate
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
Osimertinib dimesylate
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
Osimertinib dimesylate图片
CAS NO:2070014-82-1
包装与价格:
包装价格(元)
10 mM * 1 mL in Water电议
5mg电议
10mg电议
50mg电议
100mg电议
200mg电议
500mg电议
1 g电议
5 g电议

产品名称
奥希替尼二甲磺酸盐
AZD-9291 dimesylate
Mereletinib dimesylate
产品介绍
Osimertinib dimesylate (AZD-9291 dimesylate) 是不可逆的突变体选择性EGFR抑制剂;对EGFRL858R和EGFRL858R/T790MIC50值分别为12 和 1 nM。
生物活性

Osimertinib dimesylate (AZD-9291 dimesylate) is an irreversible and mutant selectiveEGFRinhibitor withIC50s of 12 and 1 nM againstEGFRL858RandEGFRL858R/T790M, respectively.

IC50& Target[1]

EGFRL858R

12 nM (IC50)

EGFRL858R/T790M

1 nM (IC50)

体外研究
(In Vitro)

Osimertinib (AZD-9291) shows similar potency to early generation tyrosine kinase inhibitor (TKIs) in inhibiting EGFR phosphorylation in EGFR cells harboring sensitising EGFR mutants including PC-9 (ex19del), H3255 (L858R) and H1650 (ex19del), with mean IC50values ranging from 13 to 54 nM for Osimertinib (AZD-9291). Osimertinib (AZD-9291) also potently inhibits phosphorylation of EGFR in T790M mutant cell lines (H1975 (L858R/T790M), PC-9VanR (ex19del/T790M), with mean IC50potency less than 15 nM[1].

体内研究
(In Vivo)

The tumor-bearing mice are treated with Osimertinib (AZD-9291) (5 mg/kg/day) for one to two weeks. Within days of treatment, 5 of 5 C/L858R mice displays nearly 80% reduction in tumor volume by magnetic resonance imaging MRI after therapy with Osimertinib (AZD-9291), while 5 of 5 mice treated with vehicle shows tumor growth[1]. Osimertinib (AZD-9291) demonstrates improved rat PK, reduced hERG affinity, and improved IGF1R margins relative to the previously described compounds, and so this compound is selected for further investigation. Osimertinib (AZD-9291) also offers an additional degree of broader chemical and profile diversity when compared to the previously described lead compounds. Upon dosing Osimertinib (AZD-9291) in three efficacy models, The comparable efficacy is observed at relatively low doses (10 mg/kg per day). The excellent efficacy is also observed when Osimertinib (AZD-9291) is dosed at 5 mg/kg per day[2].

Clinical Trial
分子量

691.82

性状

Solid

Formula

C30H41N7O8S2

CAS 号

2070014-82-1

中文名称

奥斯替尼二甲磺酸盐;奥希替尼二甲磺酸盐

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

4°C, sealed storage, away from moisture

*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

溶解性数据
In Vitro: 

H2O : 100 mg/mL(144.55 mM;Need ultrasonic)

DMSO : 2.63 mg/mL(3.80 mM;Need ultrasonic)

配制储备液
浓度溶剂体积质量1 mg5 mg10 mg
1 mM1.4455 mL7.2273 mL14.4546 mL
5 mM0.2891 mL1.4455 mL2.8909 mL
10 mM0.1445 mL0.7227 mL1.4455 mL
*

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效
储备液的保存方式和期限:-80℃, 6 months; -20℃, 1 month (sealed storage, away from moisture)。-80℃ 储存时,请在 6 个月内使用,-20℃ 储存时,请在 1 个月内使用。